CarepathRx Acquired by Cigna — Healthcare M&A

Cigna has announced the acquisition of CarepathRx, a hospital-focused pharmacy that dispenses prescription drugs. The deal is structured as an add-on acquisition, with the purchase price undisclosed. CarepathRx is backed by private equity and serves nearly 10% of U.S. hospitals, expanding Cigna’s footprint beyond health insurance into direct participation in the prescription drug supply chain. The transaction was announced in Texas, where CarepathRx is based.

The move aligns with Cigna’s broader strategy of vertical integration in healthcare, aimed at gaining more control over how prescription drugs are managed and delivered. It follows Cigna’s earlier expansion into pharmacy services through its acquisition of Express Scripts in 2018, and it reflects a wider industry trend in which insurers seek to influence pharmaceutical costs and utilization by owning more of the infrastructure between payers and providers. The consolidation dynamic has also drawn scrutiny from antitrust authorities concerned that increased market concentration could affect pricing and consumer outcomes.

While specific financial terms and closing conditions were not disclosed, the announcement reinforces Cigna’s emphasis on prescription drug management as a strategic priority. The acquisition is expected to deepen Cigna’s role in hospital pharmacy operations and further integrate its services across the U.S. healthcare system.